Molecular Testing for Fine-Needle Aspiration of Pancreatic Cystic Lesions. Issue 4 (July 2015)

• Record Type: Journal Article
• Authors: Adhikari, Laura J.; Collins, Brian T.
• Is Part Of: Pathology case reviews. Volume 20:Issue 4(2015)
• Publication Date: 2015-07
• Subjects: Diagnosis, Laboratory -- Periodicals; Pathology -- Case studies -- Periodicals; Pathology, Clinical -- Case Reports; Pathology, Clinical -- Periodicals; Diagnosis, Laboratory; Pathology; Case studies; Periodicals; Case Reports; Periodicals; Electronic journals; 616.07
• DOI: 10.1097/PCR.0000000000000093
• Languages: English
• ISSNs: 1082-9784

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>The incidence of pancreatic cysts in the general population is relatively low, with approximately 2.6% of the adult population and 8% of the elderly population having pancreatic cystic lesions at autopsy. It is now estimated that intraductal papillary mucinous neoplasms account for approximately 3% to 5% of pancreatic neoplasms and 6% of mucinous cystic neoplasms. Serous cystadenomas account for approximately 10% to 15% of cystic lesions of the pancreas, with perhaps an even higher percentage with today's higher-quality precision imaging studies. In an attempt to standardize a systemic approach to pancreatic cystic lesions, an international multidisciplinary group of physicians met in Sendai, Japan, in 2005, and again revised in 2010, to create guidelines based on treatment outcomes.</p> </sec> </abstract>